| Lyndsay Mitchell, CNS | |
|
429 E Vermont St Ste 306, Indianapolis, IN 46202-3698 | |
| (317) 338-4800 | |
| Not Available |
| Full Name | Lyndsay Mitchell |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 14 Years |
| Location | 429 E Vermont St Ste 306, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740490911 | NPI | - | NPPES |
| 200988250 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 71003292A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Vincent Hospital And Health Care Center, Inc. | 4981516853 | 28 |
| Hendricks County Psychotherapy Psc | 9133149420 | 18 |
News Archive
Anthera Pharmaceuticals, Inc., today announced financial results and business highlights for the second quarter ended June 30, 2010.
The Cancer Genome Atlas (TCGA) will fund an effort by scientists at The University of Texas M. D. Anderson Cancer Center to siphon buckets of meaningful information from an ocean of data about the aberrant genetics that drive human cancers.
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
Teasing out the exact type or types of dementia someone suffers from is no easy task; neurodegenerative brain diseases share common pathology and often co-occur. Researchers from the Perelman School of Medicine at the University of Pennsylvania are continuing efforts to differentiate diseases, such as Alzheimer's disease (AD) from frontotemporal lobar degeneration (FTLD), as FTLD is often clinically difficult to distinguish from atypical presentations of AD.
› Verified 8 days ago
| Entity Name | St. Vincent Hospital & Health Care Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689869893 PECOS PAC ID: 4981516853 Enrollment ID: O20040712000933 |
News Archive
Anthera Pharmaceuticals, Inc., today announced financial results and business highlights for the second quarter ended June 30, 2010.
The Cancer Genome Atlas (TCGA) will fund an effort by scientists at The University of Texas M. D. Anderson Cancer Center to siphon buckets of meaningful information from an ocean of data about the aberrant genetics that drive human cancers.
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
Teasing out the exact type or types of dementia someone suffers from is no easy task; neurodegenerative brain diseases share common pathology and often co-occur. Researchers from the Perelman School of Medicine at the University of Pennsylvania are continuing efforts to differentiate diseases, such as Alzheimer's disease (AD) from frontotemporal lobar degeneration (FTLD), as FTLD is often clinically difficult to distinguish from atypical presentations of AD.
› Verified 8 days ago
| Entity Name | Hendricks County Psychotherapy Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295877900 PECOS PAC ID: 9133149420 Enrollment ID: O20051201000418 |
News Archive
Anthera Pharmaceuticals, Inc., today announced financial results and business highlights for the second quarter ended June 30, 2010.
The Cancer Genome Atlas (TCGA) will fund an effort by scientists at The University of Texas M. D. Anderson Cancer Center to siphon buckets of meaningful information from an ocean of data about the aberrant genetics that drive human cancers.
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
Teasing out the exact type or types of dementia someone suffers from is no easy task; neurodegenerative brain diseases share common pathology and often co-occur. Researchers from the Perelman School of Medicine at the University of Pennsylvania are continuing efforts to differentiate diseases, such as Alzheimer's disease (AD) from frontotemporal lobar degeneration (FTLD), as FTLD is often clinically difficult to distinguish from atypical presentations of AD.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lyndsay Mitchell, CNS 8840 Commerce Park Pl Ste E, Indianapolis, IN 46268-3129 Ph: () - | Lyndsay Mitchell, CNS 429 E Vermont St Ste 306, Indianapolis, IN 46202-3698 Ph: (317) 338-4800 |
News Archive
Anthera Pharmaceuticals, Inc., today announced financial results and business highlights for the second quarter ended June 30, 2010.
The Cancer Genome Atlas (TCGA) will fund an effort by scientists at The University of Texas M. D. Anderson Cancer Center to siphon buckets of meaningful information from an ocean of data about the aberrant genetics that drive human cancers.
Aradigm Corporation today announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (ARD-3100) in patients with non-cystic fibrosis bronchiectasis (BE) under a U.S. IND. This orphan disease indication is a chronic, severe respiratory disease and there are currently no approved treatments for this disease in the U.S.
Teasing out the exact type or types of dementia someone suffers from is no easy task; neurodegenerative brain diseases share common pathology and often co-occur. Researchers from the Perelman School of Medicine at the University of Pennsylvania are continuing efforts to differentiate diseases, such as Alzheimer's disease (AD) from frontotemporal lobar degeneration (FTLD), as FTLD is often clinically difficult to distinguish from atypical presentations of AD.
› Verified 8 days ago
Sheryl Ann Terzini, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 7250 Clearvista Drive, Suite 227, Indianapolis, IN 46256 Phone: 317-621-7804 Fax: 317-621-7275 | |
Johnny Valito Toles Sr., LPN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1635 N Arlington Ave, Indianapolis, IN 46218 Phone: 317-353-6000 | |
Megan Zondor, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1701 N Senate Ave, Indianapolis, IN 46202 Phone: 317-847-0991 | |
Jennifer L Dickinson, NP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 720 Eskenazi Ave, Indianapolis, IN 46202 Phone: 317-880-8211 | |
David Beatty, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1001 W 10th St, Indianapolis, IN 46202 Phone: 317-630-8485 | |
Ms. Raenita D Mears, MSN RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1481 W 10th St, Indianapolis, IN 46202 Phone: 317-988-9013 | |
Dr. Alyson Yvonne Keen, PHD, RN, ACNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1701 N Senate Ave, Indianapolis, IN 46202 Phone: 317-341-3060 |